High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer-Reference-Cited by-同舟云学术

High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer

Author:

Paulsson Janna¹,Rydén Lisa²³,Strell Carina¹,Frings Oliver¹,Tobin Nicholas P¹,Fornander Tommy¹,Bergh Jonas¹⁴,Landberg Göran⁵,Stål Olle⁶,Östman Arne¹

Affiliation:

1. Department of Oncology-Pathology; Cancer Center Karolinska, Karolinska Institutet; Stockholm Sweden

2. Division of Surgery, Department of Clinical Sciences; Lund University; Lund Sweden

3. Department of Surgery; Skåne University Hospital; Lund Sweden

4. Radiumhemmet, Karolinska University Hospital; Stockholm Sweden

5. Department of Pathology; Sahlgrenska Cancer Centre, University of Gothenburg; Gothenburg Sweden

6. Department of Clinical and Experimental Medicine; Oncology, Linköping University; Linköping Sweden

Funder

Swedish Research Council (STARGET network)

Breast Cancer Theme Center (BRECT) at Karolinska Institutet

Swedish Cancer Society

Radiumhemmet and Stockholm County Council (ALF)

Karolinska Institutet-Astra Zeneca

Knut and Alice Wallenberg

The Swedish Breast Cancer Association

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference26 articles.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献